Tenofovir-induced renal tubular dysfunction among human immunodeficiency virus patients on antiretroviral therapy in Nigeria: Prospects for early detection of presymptomatic nephrotoxicity
Irikefe Paul Obiebi, Ebube Amalachukwu Nwannadi
Kidney Res Clin Pract. 2018;37(3):230-238.   Published online 2018 Sep 30     DOI: https://doi.org/10.23876/j.krcp.2018.37.3.230
Citations to this article as recorded by Crossref logo
A review of Tenofovir Disoproxil Fumarate associated nephrotoxicity among People Living with HIV: Burden, risk factors and solutions
Edwin Sam Asirvatham, Varsha Ranjan, Chhavi Garg, Charishma Jones Sarman, Mahalingam Periasamy, Vijay Yeldandi, Sunita Upadhyaya, Bhawna Rao
Clinical Epidemiology and Global Health.2024; 25: 101462.     CrossRef
Metabolism Pathways of Major Therapeutics for Treating Monkeypox Mono- and Co-infection with Human Immunodeficient Virus or SARS-CoV-2
Daisy Yan, Bingfang Yan
Current Drug Metabolism.2023; 24(4): 240.     CrossRef
Tenofovir Disoproxil Fumarate-Associated Renal Dysfunction Among Adult People Living with HIV at the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia, 2019: A Comparative Retrospective Cohort Study
Simachew Gidey Debeb, Achenef Asmamaw Muche, Zemene Demelash Kifle, Faisel Dula Sema
HIV/AIDS - Research and Palliative Care.2021; Volume 13: 491.     CrossRef
Lactobacillus rhamnosusGG attenuates tenofovir disoproxil fumarate-induced bone loss in male miceviagut-microbiota-dependent anti-inflammation
Hao Liu, Ranli Gu, Wei Li, Wen Zhou, Zhe Cong, Jing Xue, Yunsong Liu, Qiang Wei, Yongsheng Zhou
Therapeutic Advances in Chronic Disease.2019; 10: 204062231986065.     CrossRef